ArticleJournal of experimental & clinical cancer research : CR2018

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.

Xiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.